CereVasc, Inc. announced the completion of enrollment in its ETCHES 1 study of the company’s eShunt system for the treatm ...
BOSTON, Oct. 3, 2023 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced a milestone thirtieth patient received ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The FDA has granted 510(k) clearance to a ...
Few scientists doubt that backed-up clearance of detritus from the brain correlates with accumulation of amyloid plaques and neurofibrillary tangles. But which comes first? Data presented at the 9th ...
The MarketWatch News Department was not involved in the creation of this content. Landmark study demonstrates safety and performance of the eShunt System in the treatment of communicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results